Literature DB >> 10797593

ApoE polymorphism accounts for only part of the genetic variation in quantitative ApoE levels.

M C Neale1, P de Knijff, L M Havekes, D I Boomsma.   

Abstract

ApoE levels and chromosome 19 ApoE polymorphisms were measured in a sample of 156 Dutch families. Each pedigree consisted of parents aged 35-65 years and their twin offspring aged 14-21 years. A significant effect of the chromosome 19 apoE locus on quantitative plasma levels of apolipoprotein E was observed. The ApoE polymorphism explained 16% of the variance in ApoE levels. Tests of association of ApoE levels with the apoC1 locus, which is in complete linkage disequilibrium with the ApoE locus, also showed a significant effect, although the variance explained by ApoC1 was only 1%. Examination of the covariance between twins classified according to allele sharing indicates that the association is not due to population stratification, but to a genuine effect of the ApoE locus on levels. However, the ApoE locus accounts for only one-fourth of the genetic variation in ApoE levels. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797593     DOI: 10.1002/(SICI)1098-2272(200004)18:4<331::AID-GEPI6>3.0.CO;2-V

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  7 in total

1.  Apolipoproteins AI/B/E gene polymorphism and their plasma levels in patients with coronary artery disease in a tertiary care-center of Eastern India.

Authors:  Santanu Biswas; Pradip K Ghoshal; Bhubaneswar Halder; Kajal Ganguly; Arup DasBiswas; Nripendranath Mandal
Journal:  Indian Heart J       Date:  2013-10-30

2.  Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals.

Authors:  Madhav Thambisetty; Romina Tripaldi; Joanna Riddoch-Contreras; Abdul Hye; Yang An; James Campbell; Jitka Sojkova; Anna Kinsey; Steven Lynham; Yun Zhou; Luigi Ferrucci; Dean F Wong; Simon Lovestone; Susan M Resnick
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.

Authors:  Daniel Johnstone; Elizabeth A Milward; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

4.  ApoE plasma levels and risk of cardiovascular mortality in old age.

Authors:  Simon P Mooijaart; Jimmy F P Berbée; Diana van Heemst; Louis M Havekes; Anton J M de Craen; P Eline Slagboom; Patrick C N Rensen; Rudi G J Westendorp
Journal:  PLoS Med       Date:  2006-05-09       Impact factor: 11.069

5.  Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer's disease.

Authors:  Chong Wang; Jin-Tai Yu; Hui-Fu Wang; Teng Jiang; Chen-Chen Tan; Xiang-Fei Meng; Holly D Soares; Lan Tan
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

6.  Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort.

Authors:  Katrine L Rasmussen; Anne Tybjærg-Hansen; Børge G Nordestgaard; Ruth Frikke-Schmidt
Journal:  Eur Heart J       Date:  2019-09-01       Impact factor: 29.983

7.  Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease.

Authors:  Carlos O Mendivil; Eric B Rimm; Jeremy Furtado; Frank M Sacks
Journal:  J Am Heart Assoc       Date:  2013-05-14       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.